Get Live Data

We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

  2. Share Prices
  3. Biopharma Cred. Share Price
  4. Biopharma Cred. Share Regulatory News
  5. STATEMENT RE IMMUNOGEN, INC.

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Biopharma Cred. Information

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.874
Bid: 0.874
Ask: 0.876
Change: -0.004 (-0.46%)
Spread: 0.002 (0.229%)
Open: 0.876
High: 0.878
Low: 0.874
Prev. Close: 0.878
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

STATEMENT RE IMMUNOGEN, INC.

13 Feb 2024 07:00

RNS Number : 9464C
BioPharma Credit PLC
13 February 2024
 

BioPharma Credit PLC

13 February 2024

 

 

 

 

BIOPHARMA CREDIT PLC

 

(THE "COMPANY")

 

STATEMENT RE ImmunoGen, Inc.

 

Pharmakon Advisors, LP, the investment manager of the Company, notes the announcement released 12 February 2024 by AbbVie Inc. ("AbbVie") regarding the completion of its acquisition of ImmunoGen, Inc. ("IMGN") (such acquisition, the "Transaction"). AbbVie and IMGN had previously announced the entering into of a definitive agreement regarding the Transaction on Thursday 30 November 2023.

 

The Company announced on 11 April 2023 an investment in a senior secured loan to IMGN of up to US$62.5 million in up to two tranches. The Company had previously funded the first tranche representing a US$37.5 million investment, which was prepaid upon the closing of the Transaction. The Company received US$50.6 million in total, including $13.1 million of accrued interest, additional consideration, and prepayment and make-whole fees.

 

Enquiries:

BioPharma Credit plc

via Link Company Matters Limited

Company Secretary

+44 (0)1392 477 509

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRGPUUCPUPCUQW
12345678910
Date   Source Headline
26th Apr 20246:15 pmRNSTransaction in Own Shares
24th Apr 20246:15 pmRNSTransaction in Own Shares
24th Apr 20247:00 amRNSNEW INVESTMENT OF UP TO US$100 MILLION
23rd Apr 20246:15 pmRNSTransaction in Own Shares
22nd Apr 20246:15 pmRNSTransaction in Own Shares
22nd Apr 20244:00 pmRNSNet Asset Value(s) and Monthly Factsheet
19th Apr 20246:15 pmRNSTransaction in Own Shares
18th Apr 20246:15 pmRNSTransaction in Own Shares
18th Apr 20246:00 pmRNSNotice of AGM
17th Apr 20246:15 pmRNSTransaction in Own Shares
16th Apr 20246:15 pmRNSTransaction in Own Shares
15th Apr 20246:15 pmRNSTransaction in Own Shares
12th Apr 20246:15 pmRNSTransaction in Own Shares
11th Apr 20246:15 pmRNSTransaction in Own Shares
10th Apr 20246:15 pmRNSTransaction in Own Shares
9th Apr 20246:15 pmRNSTransaction in Own Shares
8th Apr 20246:15 pmRNSTransaction in Own Shares
4th Apr 20246:15 pmRNSTransaction in Own Shares
3rd Apr 20246:15 pmRNSTransaction in Own Shares
2nd Apr 20246:15 pmRNSTransaction in Own Shares
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
27th Mar 20247:01 amRNSUPDATES TO THE DISCOUNT CONTROL MECHANISM
27th Mar 20247:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
25th Mar 202411:35 amRNSDirector/PDMR Shareholding
21st Mar 20244:05 pmRNSDividend Declaration
21st Mar 20244:00 pmRNSNet Asset Value(s)
15th Mar 20244:35 pmRNSUPDATE ON INVESTMENT
11th Mar 20244:00 pmRNSNet Asset Value(s) and Monthly Factsheet
1st Mar 20243:10 pmRNSTotal Voting Rights
27th Feb 20247:00 amRNSNotice of Full Year Results
26th Feb 20246:15 pmRNSTransaction in Own Shares
20th Feb 20246:15 pmRNSTransaction in Own Shares
19th Feb 20246:15 pmRNSTransaction in Own Shares
16th Feb 20246:15 pmRNSTransaction in Own Shares
13th Feb 20246:15 pmRNSTransaction in Own Shares
13th Feb 20247:00 amRNSSTATEMENT RE IMMUNOGEN, INC.
9th Feb 20246:15 pmRNSTransaction in Own Shares
8th Feb 20246:15 pmRNSTransaction in Own Shares
8th Feb 20247:00 amRNSDividend Declaration
7th Feb 20246:15 pmRNSTransaction in Own Shares
6th Feb 20246:15 pmRNSTransaction in Own Shares
6th Feb 20247:00 amRNSSTATEMENT RE COHERUS BIOSCIENCES, INC.
1st Feb 202410:39 amRNSTotal Voting Rights
31st Jan 20244:00 pmRNSNet Asset Value(s) and Monthly Factsheet
30th Jan 20246:15 pmRNSTransaction in Own Shares
29th Jan 20246:15 pmRNSTransaction in Own Shares
26th Jan 20246:15 pmRNSTransaction in Own Shares
25th Jan 20246:15 pmRNSTransaction in Own Shares
24th Jan 20246:15 pmRNSTransaction in Own Shares
23rd Jan 20246:15 pmRNSTransaction in Own Shares
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.